Literature DB >> 28225978

Daylight photodynamic therapy - Experience and safety in treatment of actinic keratoses of the face and scalp in low latitude and high brightness region.

Luiz Eduardo Garcia Galvão1, Heitor de Sá Gonçalves1, Karine Paschoal Botelho1, Juliana Chagas Caldas1.   

Abstract

Daylight photodynamic therapy has been used in countries with high latitudes during the summer for actinic keratoses treatment with reports of similar efficacy to conventional photodynamic therapy. We evaluate its safety in 20 patients in the city of Fortaleza, a local with low latitude and high brightness. Sixteen patients did not report any discomfort due to the procedure. Daylight photodynamic therapy is an easy application method with great tolerability by the patient and has the possibility of being performed throughout the year in these regions. It can mean a promising tool in the control of skin cancer.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28225978      PMCID: PMC5312200          DOI: 10.1590/abd1806-4841.20175175

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  9 in total

Review 1.  Daylight photodynamic therapy for actinic keratosis: an international consensus: International Society for Photodynamic Therapy in Dermatology.

Authors:  S R Wiegell; H C Wulf; R-M Szeimies; N Basset-Seguin; R Bissonnette; M-J P Gerritsen; Y Gilaberte; P Calzavara-Pinton; C A Morton; A Sidoroff; L R Braathen
Journal:  J Eur Acad Dermatol Venereol       Date:  2011-12-23       Impact factor: 6.166

2.  Adherence to a topical regimen of 5-fluorouracil, 0.5%, cream for the treatment of actinic keratoses.

Authors:  Brad Yentzer; Jeff Hick; Lisa Williams; Robin Inabinet; Rebekah Wilson; Fabian T Camacho; Gregory B Russell; Steven R Feldman
Journal:  Arch Dermatol       Date:  2009-02

3.  Daylight photodynamic therapy for actinic keratoses in São Paulo, Brazil.

Authors:  Beni Moreinas Grinblat; Cyro Festa Neto; Jose Antonio Sanches; Rolf-Markus Szeimies; Amauri Pereira Oliveira; Luis Antonio Ribeiro Torezan
Journal:  Photodermatol Photoimmunol Photomed       Date:  2014-06-09       Impact factor: 3.135

4.  Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005.

Authors:  Lasse R Braathen; Rolf-Markus Szeimies; Nicole Basset-Seguin; Robert Bissonnette; Peter Foley; David Pariser; Rik Roelandts; Ann-Marie Wennberg; Colin A Morton
Journal:  J Am Acad Dermatol       Date:  2007-01       Impact factor: 11.527

5.  Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.

Authors:  D M Rubel; L Spelman; D F Murrell; J-A See; D Hewitt; P Foley; C Bosc; D Kerob; N Kerrouche; H C Wulf; S Shumack
Journal:  Br J Dermatol       Date:  2014-10-20       Impact factor: 9.302

Review 6.  A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.

Authors:  Boudewijn J M Braakhuis; Maarten P Tabor; J Alain Kummer; C René Leemans; Ruud H Brakenhoff
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

7.  Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study.

Authors:  S R Wiegell; M Haedersdal; P A Philipsen; P Eriksen; C D Enk; H C Wulf
Journal:  Br J Dermatol       Date:  2008-02-19       Impact factor: 9.302

8.  A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study.

Authors:  M Freeman; C Vinciullo; D Francis; L Spelman; R Nguyen; P Fergin; K-E Thai; D Murrell; W Weightman; C Anderson; C Reid; A Watson; P Foley
Journal:  J Dermatolog Treat       Date:  2003-06       Impact factor: 3.359

Review 9.  Cutaneous field cancerization: clinical, histopathological and therapeutic aspects.

Authors:  Luís Antônio Ribeiro Torezan; Cyro Festa-Neto
Journal:  An Bras Dermatol       Date:  2013 Sep-Oct       Impact factor: 1.896

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.